Minimally invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)
Ask the expert
Report presents summary of reimbursement situation for procedures to treat gastro-esophageal reflux disease (GERD) in European countries.
Four minimally invasive procedures are considered in the report:
- Radiofrequency ablation
- Endoscopic plication and suturing
- Injection of bulking agents
Report includes essential information about reimbursement and national funding, including:
- Brief overview of reimbursement system for medical devices
- Procedure coding for technology
- Diagnosis coding
- Payment mechanism for technology
- Reimbursement tariffs for technology
- Restrictions in indications or scenarios for use of technology
- Policy considerations by payers and policy-makers about technology
Reimbursement information is provided for the following geographies:
- Austria
- Belgium
- Denmark
- England (UK)
- France
- Germany
- Italy
- Netherlands
- Norway
- Sweden
- Switzerland
It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.
Manufacturers of devices for endoluminal treatment of gastro-esophageal reflux disease (GERD) include:
Radiofrequency ablation
- Mederi Therapeutics (Stretta System)
- Medtronic (Barrx radiofrequency ablation system)
Endoscopic plication and suturing
- Apollo Endosurgery (OverStitch Endoscopic Suturing System)
- C.R.Bard (EndoCinch device)
- Endogastric Solutions (EsophyX System)
- Medigus (SRS Endoscopic Stapling System)
- Medtronic (Gatekeeper Reflux Repair System)
Injection of bulking agents
- Carbon Medical Technologies (Durasphere GR)
Endoscopic augmentation of the lower oesophageal sphincter using hydrogel implants
- Boston Scientific (Enteryx Device)
- Medtronic (Gatekeeper Reflux Repair System)
Table of content is not available at the moment.
25
Mar 2022
On March 4, 2022, the Dutch Healthcare Institute (Zorginstituut Nederland, ZIN) announced three projects which received a subsidy under the "Subsidy scheme for promising care" in 2022 for research of a new minimally invasive endoscopy-guided surgery in patients with spontaneous cerebral hemorrhage, oral immunotherapy in children to cure a food allergy and cutting the diaphragm band in chronic abdominal complaints.
Read more10
Mar 2022
In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.
Read more09
Mar 2022
On February 16, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) has published the decisions which recommended the transfer to standard care for three completed projects. The projects relate to the prevention of antibiotic resistance, improvement of healthcare in socially disadvantaged areas, and misuse of control colonoscopies in Germany.
Read more14
Feb 2022
On January 28, 2022, the Institute for the Hospital Remuneration System (InEK) has published the list of the requests for innovation funding (NUB) that were submitted by the hospitals in 2021. The medical technologies belonging to the cardiovascular, ENT, eHealth, gastrointestinal, neuromodulation, neurovascular, orthopedic, and other technology groups obtained positive status 1.
Read more18
Jan 2022
In December 2021, the National Institute for Health and Care Excellence (NICE) published two new Interventional Procedure Guidance (endobronchial nerve ablation for chronic obstructive pulmonary disease and transanal total mesorectal excision for rectal cancer), two new Medical Technologies Guidance (ClearGuard HD antimicrobial barrier caps, and Endo-SPONGE for treating low rectal anastomotic leak), and one new Medtech Innovation Briefings (FreeO2 automatic oxygen titration). Also, one new clinical guideline was published, and five were updated.
Read more